As January comes to an end, here’s a clear snapshot of where pharmaceutical track & trace in Egypt stands today.
Egypt officially announced in late 2025 the implementation of a national pharmaceutical track & trace system, covering:
=Serialization & Aggregation
=Imported products starting February2026
=Locally manufactured products starting August 2026
Decision 604 defined:
=Mandatory reporting events
=Responsibilities of each supply chain entity
=Clear compliance expectations
SAP has been selected as the technology provider for the national hub,
Imported products registration (phased approach)
According to informed sources quoted by Al-Mal Newspaper:
Imported products will not be registered all at once,Registration will be phased.
Phase 1
Starts second week of February
Runs for 3 months
No new imported SKUs added during this phase
Phase 2
Opens after Phase 1
Adds new imported products,copmanies
Also runs for 3 months
Pilot phase
The pilot will be controlled and limited:
57 pharmacies owned by the Egyptian Company for Trading Pharmaceuticals
Distributors involved:
Egyptian Company for Trading Pharmaceuticals
Ibn Sina
Pharma Overseas
Scope includes:
A limited number of imported products
Narcotic medicines, dispensed exclusively through ambulance pharmacies
Market Overview
4 billion packs sold in 2025 (vs. 3.5 billion in 2024)
Market value: USD 8.8 billion (vs. USD 6.2 billion)
Local manufacturing ~91%Represents 70% of sales value
Imports ~9% Represent 30% of sales value
Infrastructure:
~180 local manufacturers
~1,600 warehouses
~80,000 pharmacies (not all active)
~12,000 registered products